TrialResults-center.org

Menu

Description Results NMA

Group by...

in first

in second

in third

pdf

pathology

Demonstrated benefit and harm

k

acute coronary syndrome

versus placebo or control

No demonstrated result for efficacy

Trial

control

p<0.05

harm

NS

Modena

trapidil vs placebo

Vasc events 0.21 [0.05; 0.91]

cardiovascular events 0.21 [0.05; 0.91]

Vasc deaths 0.21 [0.02; 1.72]

Non-fatal MI 0.21 [0.02; 1.72]

Trial

Treatments

Patients

Method

Modena

trapidil (n=71)

vs.

(n=73)

Sample size: 71/73

Primary endpoint:

FU duration: 6m

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -